Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia

Alzheimer's and Dementia

Volumn 9, Issue 5, 2013, Pages 488-498

  Vermeiren, Yannick ^a   Le Bastard, Nathalie ^a   Van Hemelrijck, An ^e   Drinkenburg, Wilhelmus H ^e   Engelborghs, Sebastiaan ^a,b   De Deyn, Peter P ^a,b,c,d  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b Hospital Network Antwerp ZNA Middelheim and Hoge Beuken   (Belgium)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

Alzheimer's disease; Amino acids; Biogenic amines and metabolites; BPSD; Cerebrospinal fluid; Dementia; Neurochemistry

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; AMINO ACID; GLUTAMIC ACID; HOMOVANILLIC ACID; NEUROTRANSMITTER; TAURINE;

ADULT; AGED; AGITATION; ALZHEIMER DISEASE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CEREBROSPINAL FLUID; CEREBROVASCULAR DISEASE; DEMENTIA; DEPRESSION; FEMALE; FLUORESCENCE; FRONTOTEMPORAL DEMENTIA; HALLUCINATION; HUMAN; LEWY BODY; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PHOBIA; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ALZHEIMER'S DISEASE; AMINO ACIDS; BIOGENIC AMINES AND METABOLITES; BPSD; CEREBROSPINAL FLUID; DEMENTIA; NEUROCHEMISTRY;

AGED; AMINO ACIDS; BIOGENIC AMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEMENTIA; FEMALE; HUMANS; MALE; MENTAL DISORDERS; NEUROTRANSMITTER AGENTS;

EID: 84883554401     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.06.010     Document Type: Article

References (52)

1. S.I. Finkel, J. Costa e Silva, G. Cohen, S. Miller, and N. Sartorius Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment Int Psychogeriatr 8 1996 497 500 (Pubitemid 27229556)
2. B. Reisberg, J. Borenstein, S.P. Salob, S.H. Ferris, E. Franssen, and A. Georgotas Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment J Clin Psychiatry 48 1987 9 15 (Pubitemid 17091427)
3. E.A. Weamer, J.E. Emanuel, D. Varon, S. Miyahara, P.A. Wilkosz, and O.L. Lopez The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis Int Psychogeriatr 21 2009 78 85
4. S. Finkel Introduction to behavioural and psychological symptoms of dementia (BPSD) Int J Geriatr Psychiatry 15 2000 2 4
5. M.S. Beeri, P. Werner, M. Davidson, and S. Noy The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients Int J Geriatr Psychiatry 17 2002 403 408
6. S. Engelborghs, E. Vloeberghs, N. Le Bastard, M. Van Buggenhout, P. Mariën, and N. Somers The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia Neurochem Int 52 2008 1052 1060
7. N. Herrmann, K.L. Lanctôt, and L.R. Khan The role of norepinephrine in the behavioral and psychological symptoms of dementia J Neuropsychiatry Clin Neurosci 16 2004 261 276 (Pubitemid 39244552)
8. K.L. Matthews, C.P. Chen, M.M. Esiri, J. Keene, S.L. Minger, and P.T. Francis Noradrenergic changes, aggressive behavior, and cognition in patients with dementia Biol Psychiatry 51 2002 407 416 (Pubitemid 34251178)
9. A. Lanari, F. Amenta, G. Silvestrelli, D. Tomassoni, and L. Parnetti Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease Mech Ageing Dev 127 2006 158 165 (Pubitemid 43165614)
10. K.L. Lanctôt, N. Herrmann, and P. Mazzotta Role of serotonin in the behavioral and psychological symptoms of dementia J Neuropsychiatry Clin Neurosci 13 2001 5 21 (Pubitemid 32151912)
11. M. Garcia-Alloza, F.J. Gil-Bea, M. Diez-Ariza, C.P. Chen, P.T. Francis, and B. Lasheras Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease Neuropsychologia 43 2005 442 449 (Pubitemid 40222131)
12. S. Engelborghs, B. Marescau, and P.P. De Deyn Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease Neurochem Res 28 2003 1145 1150 (Pubitemid 36734544)
13. M. Garcia-Alloza, S.W. Tsang, F.J. Gil-Bea, P.T. Francis, M.K. Lai, and B. Marcos Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease Neurobiol Aging 27 2006 1110 1117 (Pubitemid 43850640)
14. D. Fekkes, T.J. van der Cammen, C.P. van Loon, C. Verschoor, F. van Harskamp, and I. de Koning Abnormal amino acid metabolism in patients with early stage Alzheimer dementia J Neural Transm 105 1998 287 294 (Pubitemid 28243236)
15. P.T. Francis Altered glutamate neurotransmission and behaviour in dementia: Evidence from studies of memantine Curr Mol Pharmacol 2 2009 77 82
16. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 1984 939 944 (Pubitemid 14076461)
17. American Psychiatric Association DSM-IV: Diagnostic and statistical manual of mental disorders 1994 American Psychiatric Association Washington, DC
18. G.C. Román, T.K. Tatemichi, T. Erkinjuntti, J.L. Cummings, J.C. Masdeu, and J.H. Garcia Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop Neurology 43 1993 250 260 (Pubitemid 23060253)
19. D. Neary, J.S. Snowden, L. Gustafson, U. Passant, D. Stuss, and S. Black Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria Neurology 51 1998 1546 1554
20. I.G. McKeith, D. Galasko, K. Kosaka, E.K. Perry, D.W. Dickson, and L.A. Hansen Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop Neurology 47 1996 1113 1124 (Pubitemid 26374873)
21. I.G. McKeith, D.W. Dickson, J. Lowe, M. Emre, J.T. O'Brien, and H. Feldman Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium Neurology 65 2005 1863 1872 (Pubitemid 43970103)
22. P.P. De Deyn, S. Engelborghs, J. Saerens, J. Goeman, P. Mariën, and K. Maertens The Middelheim Frontality Score: A behavioural assessment scale that discriminates frontotemporal dementia from Alzheimer's disease Int J Geriatr Psychiatry 20 2005 70 79 (Pubitemid 40089567)
23. J. Cohen-Mansfield, M.S. Marx, and A.S. Rosenthal A description of agitation in a nursing home J Gerontol 44 1989 77 84
24. G.S. Alexopoulos, R.C. Abrams, R.C. Young, and C.A. Shamoian Cornell Scale for Depression in Dementia Biol Psychiatry 23 1988 271 284 (Pubitemid 18047596)
25. B. Reisberg, S.H. Ferris, M.J. de Leon, and T. Crook The Global Deterioration Scale for assessment of primary degenerative dementia Am J Psychiatry 139 1982 1136 1139 (Pubitemid 12051593)
26. S.A. Cohen, and D.P. Michaud Synthesis of a fluorescent derivatizing reagent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acids via high-performance liquid chromatography Anal Biochem 211 1993 279 287 (Pubitemid 23207730)
27. T. Yoshitake, J. Kehr, S. Yoshitake, K. Fujino, H. Nohta, and M. Yamaguchi Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine J Chromatogr B Anal Technol Biomed Life Sci 807 2004 177 183 (Pubitemid 38759981)
28. S. Engelborghs, K. Maertens, G. Nagels, E. Vloeberghs, P. Mariën, and A. Symons Neuropsychiatric symptoms of dementia: Cross-sectional analysis from a prospective, longitudinal Belgian study Int J Geriatr Psychiatry 20 2005 1028 1037 (Pubitemid 41723573)
29. S. Engelborghs, K. De Vreese, T. Van de Casteele, H. Vanderstichele, and B. Van Everbroeck Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia Neurobiol Aging 29 2008 1143 1159 (Pubitemid 351822410)
30. E.R. Kandel, J.H. Schwartz, and T.M. Jessell Appendix C: Cerebrospinal fluid: blood-brain barrier, brain edema, and hydrocephalus L.P. Rowland, M.E. Fink, L. Rubin, Principles of neural science 3rd ed. 1991 Appleton & Lange East Norwalk, CT 1050 1051
31. P. Nowak, R.A. Kostrzewa, D. Skaba, and R.M. Kostrzewa Acute L-DOPA effect on hydroxyl radical- and DOPAC-levels in striatal microdialysates of parkinsonian rats Neurotox Res 17 2010 299 304
32. A. Borah, and K.P. Mohanakumar Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of rats Cell Mol Neurobiol 27 2007 985 996 (Pubitemid 351170075)
33. T.D. Geracioti Jr., P.E. Keck Jr., N.N. Ekhator, S.A. West, D.G. Baker, and K.K. Hill Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid Biol Psychiatry 44 1998 228 233 (Pubitemid 28378304)
34. H. Agren, I.N. Mefford, M.V. Rudorfer, M. Linnoila, and W.Z. Potter Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF J Psychiatr Res 20 1986 175 193 (Pubitemid 16017206)
35. P.R. Louzada, A.C. Paula Lima, D.L. Mendonca-Silva, F. Noel, F.G. De Mello, and S.T. Ferreira Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders FASEB J 18 2004 511 518 (Pubitemid 38326307)
36. I. Santa-Maria, F. Hernandez, F.J. Moreno, and J. Avila Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation Neurosci Lett 429 2007 91 94 (Pubitemid 350161113)
37. J.G. Csernansky, M.E. Bardgett, Y.I. Sheline, J.C. Morris, and J.W. Olney CSF excitatory amino acids and severity of illness in Alzheimer's disease Neurology 46 1996 1715 1720 (Pubitemid 26185799)
38. C.X. Li, Y. Wang, H. Gao, W.J. Pan, Y. Xiang, and M. Huang Cerebral metabolic changes in a depression-like rat model of chronic forced swimming studied by ex vivo high resolution 1H magnetic resonance spectroscopy Neurochem Res 33 2008 2342 2349
39. T. Murakami, and M. Furuse The impact of taurine- and beta-alanine-supplemented diets on behavioral and neurochemical parameters in mice: Antidepressant versus anxiolytic-like effects Amino Acids 39 2010 427 434
40. B.K. Whirley, and H. Einat Taurine trials in animal models offer no support for anxiolytic, antidepressant or stimulant effects Isr J Psychiatry Relat Sci 45 2008 11 18
41. H. Arai, K. Kobayashi, Y. Ichimiya, K. Kosaka, and R. Iizuka A preliminary study of free amino acids in the postmortem temporal cortex from Alzheimer-type dementia patients Neurobiol Aging 5 1984 319 321 (Pubitemid 15105307)
42. J. Alom, J.N. Mahy, N. Brandi, and E. Tolosa Cerebrospinal fluid taurine in Alzheimer's disease Ann Neurol 30 1991 735
43. R.J. Walters, S.H. Hadley, K.D. Morris, and J. Amin Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms Nat Neurosci 3 2000 1274 1281
44. J. Gallinat, D. Kunz, U.E. Lang, P. Neu, N. Kassim, and T. Kienast Association between cerebral glutamate and human behaviour: The sensation seeking personality trait Neuroimage 34 2007 671 678 (Pubitemid 44827774)
45. M.D. Kelland, A.S. Freeman, and L.A. Chiodo Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons J Pharmacol Exp Ther 253 1990 803 811 (Pubitemid 20181730)
46. G.H. Suh, A.J. Greenspan, and S.K. Choi Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia Int J Geriatr Psychiatry 22 2007 494 495 (Pubitemid 46831695)
47. A.L. Nyth, and C.G. Gottfries The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study Br J Psychiatry 157 1990 894 901
48. F. Roselli, N.M. Pisciotta, R. Perneczky, M. Pennelli, M.S. Aniello, and M.F. De Caro Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: A 123I-FP-CIT SPECT study Mov Disord 24 2009 2097 2103
49. J.T. O'Brien, S. Colloby, J. Fenwick, E.D. Williams, M. Firbank, and D. Burn Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies Arch Neurol 61 2004 919 925 (Pubitemid 38747333)
50. G.J. Schmitt, T. Frodl, S. Dresel, C. la Fougère, R. Bottlender, and N. Koutsouleris Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients Eur Arch Psychiatry Clin Neurosci 256 2006 115 121
51. J.G. Goldman, C.G. Goetz, M. Brandabur, M. Sanfilippo, and G.T. Stebbins Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies Mov Disord 23 2008 2248 2250
52. R.A. Sweet, B. Devlin, B.G. Pollock, D.L. Sukonick, K.B. Kastango, and S.A. Bacanu Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease Mol Psychiatry 10 2005 1026 1036 (Pubitemid 41541988)